THE VOGEL GROUP

Lobbying for HDT BIO CORP · Medical Research Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Washington · House · Senate · $20,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

Issues related to emerging biological threats and drug development

Medical/Disease Research/Clinical Labs

Issues related to emerging biological threats and drug development

Science/Technology

Issues related to emerging biological threats and drug development

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.